Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Melzi
AddedFeb 16, 2024
UpdatedJun 18, 2026
Melzi

Melzi

Series A

Melzi, an innovative surgical device company, enhances patient outcomes and cuts hospital costs.

HQ
Los Altos, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Melzi, founded with a mission to enhance patient outcomes and reduce hospital costs, is a surgical device company specializing in innovative technologies. Their flagship product, the Melzi Sharps Finder, is a U.S. FDA-registered device designed to locate instruments, needles, and broken fragments during surgeries, thereby preventing retained surgical items and managing miscounts. Melzi focuses on addressing common surgical challenges to improve efficiency and safety in operating rooms.

Notable affiliated individuals and investors in Melzi include key figures from the medical technology and healthcare investment sectors. The company has achieved significant milestones, including FDA registration for its lead product and positive feedback from early adopters in the medical community. Melzi's impact is evident in its contribution to reducing surgical errors and associated costs, positioning it as a valuable player in the surgical device market.

Melzi - Similar Companies

Miret Surgical logo

Miret Surgical

miretsurgical.com

Medical Engineering Innovations logo

Medical Engineering Innovations

mei-america.com

Tally Surgical logo

Tally Surgical

tallysurgical.com

Emet Surgical logo

Emet Surgical

emetsurgical.com

Mezlight logo

Mezlight

mezlight.com

Current Surgical logo

Current Surgical

Fulmer Instruments logo

Fulmer Instruments

Medtel.com logo

Medtel.com

medtel.com

Prescient Surgical logo

Prescient Surgical

Minimally Invasive Devices logo

Minimally Invasive Devices

Edge Surgical logo

Edge Surgical

edgesurgical.com

Razor Medical Instruments logo

Razor Medical Instruments

surgical.ai logo

surgical.ai

surgical.ai

Surgimatix logo

Surgimatix

surgimatix.com

Majelco Medical logo

Majelco Medical

majelcomedical.com

Melzi - Quick Facts

Who are Melzi's competitors?

Companies similar to Melzi include Miret Surgical, Medical Engineering Innovations, Tally Surgical and Emet Surgical.

When was Melzi founded?

Melzi was founded in 2017.

Where is Melzi's headquarters located?

Melzi's headquarters is located in Los Altos, CA, US.

When was Melzi's last funding round?

Melzi's most recent funding round was for $4M (USD) in April 2022.

How much has Melzi raised to-date?

As of Apr 11, 2022, Melzi has raised a total of $4M (USD).

How many employees does Melzi have?

Melzi has 14 employees as of Feb 4, 2024.

Melzi - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • RFID
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Surgical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified